JP2024099834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024099834A5 JP2024099834A5 JP2024075373A JP2024075373A JP2024099834A5 JP 2024099834 A5 JP2024099834 A5 JP 2024099834A5 JP 2024075373 A JP2024075373 A JP 2024075373A JP 2024075373 A JP2024075373 A JP 2024075373A JP 2024099834 A5 JP2024099834 A5 JP 2024099834A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- utr
- absent
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778841P | 2018-12-12 | 2018-12-12 | |
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US62/778,866 | 2018-12-12 | ||
| US62/778,841 | 2018-12-12 | ||
| PCT/US2019/065995 WO2020123816A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes and methods of use |
| JP2021533528A JP2022513797A (ja) | 2018-12-12 | 2019-12-12 | アネロソーム及び使用の方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533528A Division JP2022513797A (ja) | 2018-12-12 | 2019-12-12 | アネロソーム及び使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024099834A JP2024099834A (ja) | 2024-07-25 |
| JP2024099834A5 true JP2024099834A5 (enExample) | 2024-10-31 |
Family
ID=69165586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533528A Withdrawn JP2022513797A (ja) | 2018-12-12 | 2019-12-12 | アネロソーム及び使用の方法 |
| JP2024075373A Pending JP2024099834A (ja) | 2018-12-12 | 2024-05-07 | アネロソーム及び使用の方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533528A Withdrawn JP2022513797A (ja) | 2018-12-12 | 2019-12-12 | アネロソーム及び使用の方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220042042A1 (enExample) |
| EP (1) | EP3894570A2 (enExample) |
| JP (2) | JP2022513797A (enExample) |
| KR (1) | KR20210131310A (enExample) |
| CN (1) | CN113631716A (enExample) |
| AU (1) | AU2019397058A1 (enExample) |
| BR (1) | BR112021011124A2 (enExample) |
| CA (1) | CA3121528A1 (enExample) |
| IL (1) | IL283782A (enExample) |
| MX (1) | MX2021006977A (enExample) |
| WO (1) | WO2020123816A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| US11649265B2 (en) | 2017-04-28 | 2023-05-16 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
| US11812743B2 (en) | 2017-09-25 | 2023-11-14 | Agrospheres, Inc. | Compositions and methods for scalable production and delivery of biologicals |
| BR112021010925A2 (pt) * | 2018-12-12 | 2021-08-31 | Flagship Pioneering Innovations V, Inc | Anelossomos para entrega de modalidades terapêuticas de substituição de proteína |
| IL298978A (en) * | 2020-06-12 | 2023-02-01 | Flagship Pioneering Innovations V Inc | Tandem anellovirus constructs |
| BR112023012460A2 (pt) * | 2020-12-23 | 2023-11-07 | Flagship Pioneering Innovations V Inc | Conjunto in vitro de capsídeos de anellovirus que envolvem rna |
| US20240254512A1 (en) * | 2021-05-12 | 2024-08-01 | Flagship Pioneering Innovations V, Inc. | Anellovectors and methods of use |
| TW202430215A (zh) | 2022-12-14 | 2024-08-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 用於將治療劑遞送至骨之組成物和方法 |
| WO2025080985A1 (en) | 2023-10-13 | 2025-04-17 | Flagship Pioneering Innovations V, Inc. | Tissue specific anellovector delivery |
| WO2025160409A1 (en) | 2024-01-26 | 2025-07-31 | Flagship Pioneering Innovations V, Inc. | Viral vectors for modulating vegf function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| KR20160089530A (ko) * | 2013-12-12 | 2016-07-27 | 더 브로드 인스티튜트, 인코퍼레이티드 | Ｈｂｖ 및 바이러스 질병 및 질환을 위한 ｃｒｉｓｐｒｃａｓ 시스템 및 조성물의 전달，용도 및 치료적 적용 |
| KR20200038236A (ko) * | 2017-06-13 | 2020-04-10 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 큐론을 포함하는 조성물 및 그의 용도 |
| WO2020123773A2 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering secreted therapeutic modalities |
| BR112021010925A2 (pt) * | 2018-12-12 | 2021-08-31 | Flagship Pioneering Innovations V, Inc | Anelossomos para entrega de modalidades terapêuticas de substituição de proteína |
| WO2020123753A2 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering intracellular therapeutic modalities |
-
2019
- 2019-12-12 KR KR1020217021777A patent/KR20210131310A/ko not_active Ceased
- 2019-12-12 CN CN201980091082.6A patent/CN113631716A/zh active Pending
- 2019-12-12 BR BR112021011124A patent/BR112021011124A2/pt unknown
- 2019-12-12 AU AU2019397058A patent/AU2019397058A1/en active Pending
- 2019-12-12 WO PCT/US2019/065995 patent/WO2020123816A2/en not_active Ceased
- 2019-12-12 MX MX2021006977A patent/MX2021006977A/es unknown
- 2019-12-12 US US17/413,392 patent/US20220042042A1/en active Pending
- 2019-12-12 CA CA3121528A patent/CA3121528A1/en active Pending
- 2019-12-12 EP EP19836738.5A patent/EP3894570A2/en active Pending
- 2019-12-12 JP JP2021533528A patent/JP2022513797A/ja not_active Withdrawn
-
2021
- 2021-06-07 IL IL283782A patent/IL283782A/en unknown
-
2024
- 2024-05-07 JP JP2024075373A patent/JP2024099834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024100936A5 (enExample) | ||
| JP2024099834A5 (enExample) | ||
| JP2024099833A5 (enExample) | ||
| JP2024102242A5 (enExample) | ||
| JP2024088642A5 (enExample) | ||
| SANCHEZ-PESCADOR et al. | Use of unpurified synthetic deoxynucleotide primers for rapid dideoxynucleotide chain termination sequencing | |
| JP2017079759A5 (enExample) | ||
| JP2020508685A5 (enExample) | ||
| JP2003522514A5 (enExample) | ||
| JPWO2022067130A5 (enExample) | ||
| JPWO2021226436A5 (enExample) | ||
| EP1437400A3 (en) | Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus | |
| CN112469421A (zh) | 减少剪接病和治疗rna显性疾病的组合物和方法 | |
| JP2003503355A5 (enExample) | ||
| JP2005509420A5 (enExample) | ||
| JPH0322975A (ja) | 新規な逆転写酵素活性を有する蛋白 | |
| JP2023106355A5 (enExample) | ||
| Ward et al. | Structural homologies between RNA gene segments 10 and 11 from UK bovine, simian SA11, and human Wa rotaviruses | |
| CN108018267A (zh) | 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用 | |
| WO2024208970A3 (en) | Synthetic dna construct encoding transfer rna | |
| JP2021108664A5 (enExample) | ||
| JP2021508496A5 (enExample) | ||
| JPWO2021211683A5 (enExample) | ||
| Neubert et al. | Sendai virus NP gene codes for a 524 amino acid NP protein | |
| JP5502490B2 (ja) | 標的核酸を位置選択的に切断する方法 |